{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:40:34Z","timestamp":1773877234777,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372368"],"award-info":[{"award-number":["82372368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023Y0117"],"award-info":[{"award-number":["2023Y0117"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejphar.2025.178377","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:16:02Z","timestamp":1764000962000},"page":"178377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The immune thrombocytopenia therapeutic Avatrombopag alleviates osteoporosis by targeting NFATc1 signaling"],"prefix":"10.1016","volume":"1010","author":[{"given":"Yangyang","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0447-8506","authenticated-orcid":false,"given":"Kaiyin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2025.178377_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ejphar.2025.178377_bib2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.bone.2006.06.004","article-title":"Osteoclast formation and bone resorption are inhibited by megakaryocytes","volume":"39","author":"Beeton","year":"2006","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.ejphar.2025.178377_bib3","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/jcp.24943","article-title":"A novel role for thrombopoietin in regulating osteoclast development in humans and mice","volume":"230","author":"Bethel","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"9041","key":"10.1016\/j.ejphar.2025.178377_bib4","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention Trial research group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.ejphar.2025.178377_bib5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ejphar.2025.178377_bib6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMe2110953","article-title":"Immune thrombocytopenia treatment","volume":"385","author":"Bolton-Maggs","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178377_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.ejphar.2025.178377_bib8","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1056\/NEJMcp1800214","article-title":"Glucocorticoid-induced osteoporosis","volume":"379","author":"Buckley","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.ejphar.2025.178377_bib9","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1182\/blood-2013-07-514398","article-title":"A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia","volume":"123","author":"Bussel","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178377_bib10","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.7150\/thno.30206","article-title":"Pseurotin A inhibits osteoclastogenesis and prevents ovariectomized-induced bone loss by suppressing reactive oxygen species","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178377_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.afos.2018.03.003","article-title":"An updated hip fracture projection in Asia: the Asian Federation of osteoporosis societies study","volume":"4","author":"Cheung","year":"2018","journal-title":"Osteoporos Sarcopenia"},{"issue":"9319","key":"10.1016\/j.ejphar.2025.178377_bib12","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178377_bib13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bone.2004.04.005","article-title":"Reduced bone mineral density in childhood chronic idiopathic thrombocytopenic purpura treated with high-dose methylprednisolone","volume":"35","author":"Dilber","year":"2004","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.ejphar.2025.178377_bib14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJM199803123381107","article-title":"Treatment of postmenopausal osteoporosis","volume":"338","author":"Eastell","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2025.178377_bib15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.ejphar.2025.178377_bib16","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s40265-021-01553-7","article-title":"Thrombopoietin receptor agonists (TPO-RAs): drug class considerations for pharmacists","volume":"81","author":"Gilreath","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2025.178377_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jare.2023.01.003","article-title":"Obacunone targets macrophage migration inhibitory factor (MIF) to impede osteoclastogenesis and alleviate ovariectomy-induced bone loss","volume":"53","author":"He","year":"2023","journal-title":"J. Adv. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178377_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.15735","article-title":"The prevention of glucocorticoid-induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British society for haematology good practice paper","volume":"185","author":"Hill","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"7873","key":"10.1016\/j.ejphar.2025.178377_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejphar.2025.178377_bib20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bone.2006.05.004","article-title":"Megakaryocyte-mediated inhibition of osteoclast development","volume":"39","author":"Kacena","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.ejphar.2025.178377_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100909","article-title":"The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag","volume":"53","author":"Kuter","year":"2022","journal-title":"Blood Rev."},{"issue":"10","key":"10.1016\/j.ejphar.2025.178377_bib22","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos. Int."},{"issue":"16","key":"10.1016\/j.ejphar.2025.178377_bib23","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s40265-021-01613-y","article-title":"Avatrombopag: a review in thrombocytopenia","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ejphar.2025.178377_bib24","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00198-016-3553-3","article-title":"Cancel the denosumab holiday","volume":"27","author":"McClung","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178377_bib25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/jcb.25380","article-title":"C-Mpl is expressed on osteoblasts and osteoclasts and is important in regulating skeletal homeostasis","volume":"117","author":"Meijome","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"19","key":"10.1016\/j.ejphar.2025.178377_bib26","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2025.178377_bib27","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/bcp.13517","article-title":"Pharmacokinetic\/pharmacodynamic drug-drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs","volume":"84","author":"Nomoto","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178377_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","article-title":"Drug affinity responsive target stability (DARTS) for small-molecule target identification","volume":"1263","author":"Pai","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.178377_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103820","article-title":"Recent advances in the mechanisms and treatment of immune thrombocytopenia","volume":"76","author":"Provan","year":"2022","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178377_bib30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1021\/acs.jctc.0c01006","article-title":"Accelerating AutoDock4 with GPUs and gradient-based local search","volume":"17","author":"Santos-Martins","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"16","key":"10.1016\/j.ejphar.2025.178377_bib31","article-title":"NFATc1:\u03b1A- the other Face of NFAT factors in lymphocytes","volume":"10","author":"Serfling","year":"2012","journal-title":"Cell Commun. Signal."},{"issue":"11","key":"10.1016\/j.ejphar.2025.178377_bib32","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American society for bone and mineral research","volume":"25","author":"Shane","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2025.178377_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1196\/annals.1402.071","article-title":"The role of NFAT in osteoclast formation","volume":"1116","author":"Takayanagi","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2025.178377_bib34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.ejphar.2025.178377_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/09537104.2012.690544","article-title":"Bone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: relation to corticosteroid therapy and vitamin D receptor gene polymorphisms","volume":"24","author":"Tantawy","year":"2013","journal-title":"Platelets"},{"issue":"5484","key":"10.1016\/j.ejphar.2025.178377_bib36","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178377_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"D1","key":"10.1016\/j.ejphar.2025.178377_bib38","doi-asserted-by":"crossref","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.ejphar.2025.178377_bib39","doi-asserted-by":"crossref","DOI":"10.1210\/endo.138.10.5438","article-title":"Thrombopoietin inhibits in vitro osteoclastogenesis from murine bone marrow cells","volume":"138","author":"Wakikawa","year":"1997","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.ejphar.2025.178377_bib40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/MPH.0b013e318180bbc9","article-title":"Late side effects of high-dose steroid therapy on skeletal system in children with idiopathic thrombocytopenic purpura","volume":"30","author":"Yildirim","year":"2008","journal-title":"Journal of pediatric hematology\/oncology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:37:58Z","timestamp":1773851878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925011318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"alternative-id":["S0014299925011318"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178377","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immune thrombocytopenia therapeutic Avatrombopag alleviates osteoporosis by targeting NFATc1 signaling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178377"}}